The CGMP facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency
Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP-compliant Cryopreserved Leukopaks significantly decrease lead time
CPC (Colder Products Company), part of Dover and a leading manufacturer of connection technologies used in biopharmaceutical processing, medical, thermal management, and industrial applications, is expanding its footprint in Minneapolis-St. Paul.
The Prime Minister will launch the government’s new capital investment fund, the Medicines and Diagnostic Manufacturing Transformation Fund, while visiting North Wales later today. This will open up investment opportunities for medicines manufacturers in England, Scotland and Wales – improving our domestic medicine supply chains and creating thousands of highly skilled jobs in the process.
Purolite Corporation is expanding its manufacturing capabilities to address and fulfill the increasing global demand for its pharmaceutical and life science products. The new facility will include two new cleanrooms to manufacture active pharmaceutical ingredients (APIs) and excipients and an agarose manufacturing facility equipped with proprietary jetting technology for the capture and purification of (mAbs) monoclonal antibodies sold under the Praesto® brand.
SteriPack Group rapidly deploys equipment, expertise and facilities to meet critical need for sterile swabs, diagnostic products and personal protective equipment across their global manufacturing network.
ALK Life Science Solutions, a business unit of ALK-Abelló, Inc. (ALK), serving the North American pharmaceutical packaging-based market for glass vials, and UPPI, LLC, the largest association of independent and university-based nuclear pharmacies serving the diagnostic imaging community in the U.S., announced today that they have entered into a three-year partnership to provide high-quality glass vials to UPPI members providing unit dose radiopharmaceuticals and positron emission tomography (PET) manufacturing of radiopharmaceuticals for use in nuclear imaging tests and treatments.
Physician-investigators at Johns Hopkins University Hospital report on the promising data of treatment of COVID-19 induced acute respiratory distress syndrome with allogeneic, cord blood derived T-regulatory (Treg) cell therapy (manufactured by Cellenkos®), published in peer reviewed journal of Annals of Internal Medicine.
Grand River Aseptic Manufacturing (“GRAM”), an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its major $60 million expansion project and recently took occupancy.
In line with the increased focus on the medical market segment, Coveris is taking a gigantic leap forward to modernize their medical packaging production facilities. With an extensive EUR 10 m investment program, Coveris strives to become best in class when it comes to process transparency, cleanliness and quality.
Sexton Biotechnologies has announced a new collaboration with BioSpherix Medical. As a tool and technologies partners of the Cell and Gene industry, Sexton and BioSpherix both recognize the need for cost-effective and flexible automation solutions during cell and gene therapy process development. While some upstream bioprocesses have been successfully automated, the final steps of downstream bioprocess, namely Fill-Finish, are often done manually with associated risks of contamination and user error.
Integrity Cleanroom is pleased to announce that it has begun commercial transactions with a brand new ecommerce platform and a dedicated team of professionals based in Texas.